Imperagen raises £5M seed round to accelerate AI-driven enzyme engineering

Manchester techbio Imperagen has closed a £5 million seed funding round led by PXN Ventures with participation from Imperagen’s existing investors IQ Capital and Northern Gritstone. Established in 2021 by researchers from the Manchester Institute of Biotechnology, Imperagen is focused on accelerating the process of enzyme engineering. Serving diverse markets, from pharmaceutical manufacturing and life sciences to sustainable fine chemical production and industrial applications, we work hand-in-h